Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-16-000009

Options or other derivatives

  • Chief Science/Medical Officer acquired 19,016 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STRAYER DAVID R · Chief Science/Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-15 Grant or award : show line 1 in the form Incentive Rights +19,016 $0.14 $2,662 19,016 D
Loading xslF345X03/primary_doc.xml…